ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Phreesia’s Megan Turco Named to MM+M 40 Under 40

Phreesia today announced that Megan Turco, Director of Client Experience for Phreesia Network Solutions, has been named to MM+M’s 2025 40 Under 40 list.

MM+M’s annual 40 Under 40 list celebrates standout talent across healthcare marketing and communications. This year’s honorees were chosen for their impact in shaping the future of medical marketing through creativity, leadership and a commitment to a more inclusive, patient-centered industry.

“Megan has this rare ability to make operational excellence feel energizing,” said Danielle Lynch, Vice President of Client Experience at Phreesia. “She brings empathy, creativity and a whole lot of fun to the work—and that combination has been truly transformational for our business. Her passion for improving patient experiences and outcomes shows up in everything she does, and it’s exactly what makes her such an exceptional leader at Phreesia.”

Since joining Phreesia in 2018, Turco has progressed through five increasingly strategic roles, helping transform the Client Experience team from a group of four people into a mission-critical organization of more than 50 professionals. Today, Turco leads a dedicated sales team responsible for strategy, execution and growth for more than 80 life sciences and agency clients. Under her leadership, the team has exceeded its target for four consecutive years, achieving double-digit annual revenue growth year over year while launching programs that have reached millions of patients.

“Megan personifies our core values and displays incredible authenticity every day, it’s part of what makes her an exceptional leader and an inspiration to me and others,” said David Linetsky, President of Phreesia Network Solutions. “Our sales organization has a unique culture that's deeply collaborative: we win as one. The entire team is celebrating today and is tremendously proud of this well-earned recognition of Megan's accomplishments.”

Turco’s leadership has consistently delivered strong, measurable results. Internal survey data shows that 95% of clients rate their Client Experience representative as “very good” or “excellent,” while 94% say they receive great service from Phreesia. Turco is also widely regarded inside and outside the company for building culture, mentoring rising talent and strengthening long-standing client relationships.

“I’m incredibly honored to be included in MM+M’s 40 Under 40,” said Turco. “This recognition really speaks to the talent and heart of the team I get to lead. They show up every day with creativity, urgency and purpose. I’m so proud of what we’ve built together.”

For more information on Phreesia, visit www.phreesia.com.

About Phreesia

Phreesia is the trusted leader in patient activation, giving healthcare providers, life sciences companies and other organizations tools to help patients take a more active role in their care. Founded in 2005, Phreesia enabled approximately 170 million patient visits in 2024—one in seven visits across the U.S.—scale that the company believes allows it to make meaningful impact. Offering patient-driven digital solutions for intake, outreach, education and more, Phreesia enhances the patient experience, drives efficiency and improves healthcare outcomes. To learn more, visit phreesia.com.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  229.53
+0.42 (0.18%)
AAPL  278.78
-1.92 (-0.68%)
AMD  217.97
+1.99 (0.92%)
BAC  53.95
+0.07 (0.13%)
GOOG  322.09
+3.70 (1.16%)
META  673.42
+11.89 (1.80%)
MSFT  483.16
+2.32 (0.48%)
NVDA  182.41
-0.97 (-0.53%)
ORCL  217.58
+3.25 (1.52%)
TSLA  455.00
+0.47 (0.10%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.